Thursday, June 18, 2015

Gross, Gundlach, Faber Batter Bernanke as Stocks Tumble

Tough stuff from leading prognosticators in response to comments on Wednesday from Federal Reserve Chairman Ben Bernanke.

Granted, most aren’t known for their sunny optimism; but even for them it went beyond the pale. Jeffrey Gundlach doesn’t like bond alternatives; Bill Gross doesn’t like the Fed; Marc Faber doesn’t like Obama and Peter Schiff doesn’t like anybody. Judging from Wednesday’s and Thursday’s stock sell-off, they might be on to something.

The Dow Jones industrial average plunged 353 points, or 2.3%, to 14,758 points. The Dow has lost 560 points in the past two days, wiping out its gains from May and June. The Standard & Poor's 500 dropped 40 points, or 2.5%, and the Nasdaq fell 78 points, or 2.3%.

The lifeblood of America’s ailing economy—the Fed's emergency monetary infusion via quantitative easing—may be “anemic, oxygen-starved, or even leukemic,” bond king Bill Gross warned in his June missive to PIMCO shareholders. Things haven’t gotten any better since.

PIMCO co-CIO Bill GrossGross (left) told Bloomberg on Wednesday he thought Bernanke "might be driving in a fog" and said of Vice Chairman Janet Yellin, “I think she is a Siamese twin in terms of policy."

Schiff, the outspoken president of Euro Pacific Capital, was asked by the Breakout website what Bernanke could have done that would please the legendary bomb thrower.   

Peter Schiff (Photo: AP)“He could have resigned,” Schiff (right) shot back. “He’s basing his forecast of an improving economy on a housing market that was only rising because the Fed was able to blow more air back into the bubble.”

Bernanke didn’t specifically mention tapering in Wednesday’s comments because he can’t, according to Schiff.

“He knows he can’t do it. If the Fed does not start buying more than $85 billion a month of mortgages, we could have mortgage rates back above 5% by the end of this year. This whole new mini-housing boom could then be a brand new bust.”

Dr. Doom himself, Faber, editor and publisher of the aptly named "Gloom, Boom & Doom Report," recently predicted the sell-off in Japanese equities. Now he has a warning for all investors about the U.S. markets, the Fed and the rest of the world, according to Talking Numbers.

Marc Faber“[The Fed] will talk without giving any precise answers,” Faber (left) said. “I think the bond market has already weakened significantly from the July 2012 lows, in terms of yield. If the Fed indicated that it would begin tapering, equities would be more vulnerable than bonds.”

When asked about riots in emerging markets recently, and whether that made U.S. securities safe, Faber offered a glimpse of the positive before reverting to his usual pessimism.

“Yes, I would not be overly negative about U.S. bonds,” he conceded, “but it’s a more complicated question for equities.

“If someone says Mr. Bernanke has stayed to long, my view is that Mr. Obama has done the same,” Faber added with flourish.

Jeffrey Gundlach of DoubleLineAs for specific investment moves, DoubleLine Capital founder Gundlach (left) had harsh words for bond investors (recognizing he has a dog in the hunt).

"The basic viewpoint is that the financial markets, and certainly bond alternatives, are all balancing, somewhat precariously, on a very narrow base, which is zero interest rate policy,” he told CNBC. “Everybody is trying to find ways of getting yield and trying to find ways of avoiding a lousy asset class. They’re wrong, bonds are not a lousy asset class.”

The flight to bond alternatives—like dividend-paying stocks, mortgage REITs and master limited partnerships—“is going from the frying pan into the fire.”

“It’s really a fundamental mistake that investors are making,” Gundlach asserted. “They say ‘hey, I don’t want to own bonds because yields are too low, and that means that they must rise soon.’ But while bond have had modestly negative returns, these bond alternatives have had horrible returns. If the low interest rate premise is incorrect, these things will fall more than bonds.”

-----

Check out these related stories on AdvisorOne:

Wednesday, June 17, 2015

DGX to Improve Hepatitis Detection - Analyst Blog

Recently, in a bid to enhance hepatitis C virus (HCV) detection and management, Quest Diagnostics (DGX) joined forces with the US Centers for Disease Control and Prevention (CDC). Through this collaboration, the company intends to improve the public health analysis of hepatitis C screening, diagnosis as well as treatment. The process of improving Hepatitis C detection will be based on the analysis of Quest's national hepatitis C virus diagnostic information.

HCV infection is a chronic blood borne infection, which is common in the US. It acts as a major cause of liver damage and cancer. However, early diagnosis and treatment can help prevent cirrhosis, liver cancer and death.

This collaboration came on the heels of the U.S. Preventive Services Task Force's recommendation in Jun 2013, which suggested one-time hepatitis C screening for adults born between 1945 and 1965. While targeting this "baby boomer" generation, Quest noted that this age group is five times more susceptible to HCV infection than other adults. Therefore, targeting this group may prevent over 120,000 deaths.

Quest Diagnostics is optimistic about this new alliance and expects to capture a large part of the growing HCV diagnosis and treatment market in the US. At present more than 3 million people in the US are infected with hepatitis C, while many others are still unaware as to whether they are infected. Moreover, deaths from hepatitis C have doubled over the past decade to more than 15,000 a year. Thus, screening and early detection may play a vital role in curbing the fatality rate.

Currently, Quest Diagnostics has been focusing on areas with high potential such as gene-based esoteric testing for cancer, cardiovascular disease, infectious disease and neurological disorders. The company has experienced increasing demand for gene-based and esoteric tests compared to routine tests on the back of increased esoteric mix contributed by Athena and Celera. As a part of this strategy, the company completed the ! divestiture of HemoCue diagnostics products business in April.

Radiometer Medical ApS acquired the HemoCue diagnostics products business for $300 million plus customary adjustments for cash balances. Last December, the company shed its OralDNA Labs salivary-diagnostics business in order to refocus its resources on core diagnostic information services.

However, we remain cautious about Quest Diagnostics as it continues to face weak testing volume. Concerns also linger about the soft industry trends due to a decline in physician office visits, flat pricing and low organic revenues.The stock retains a Zacks Rank #4 (Sell).

While we prefer to remain bearish on Quest Diagnostics, other medical device stocks worth a look are Tornier N.V. (TRNX), Lannett Company, Inc. (LCI) andKindred Healthcare Inc. (KND). All three stocks carry a Zacks Rank #1 (Strong Buy).

Sunday, June 14, 2015

This Easy Tip Can Save You Big on Homeowners Insurance

White house in gold safeGetty Images Answer: If your deductible is $500 now, increasing it to $1,000 can lower your premiums by up to 20 percent. Most insurers offer much higher deductibles, too, which is a popular strategy for people who have enough money in emergency funds to cover potential costs. Raising your deductible is a good way to reduce your premiums, and it makes you less likely to file small claims that could result in a rate hike. At Chubb, about half of the wealthiest customers choose a deductible of $10,000 to $50,000. "For homes here in Malibu that are valued at $10 million to $25 million, having a $25,000 deductible isn't out of the ordinary at all," says Derek Ross, president of Kulchin Ross Insurance Services, an independent agency in Tarzana, Calif. The higher the deductible, the bigger the premium savings. Let's say, for example, you have a policy with Fireman's Fund with a $1,000 deductible and a $3,000 annual premium. You'd save about 24 percent by boosting your deductible to $2,500, 37 percent by raising it to $5,000, 47 percent by raising it to $10,000 and 53 percent by raising it to $25,000. Compare the premium savings with the extra dollar amount at risk to make sure that boosting your deductible is worthwhile. You should file a claim only if it is at least several hundred dollars more than the deductible. "If your insurer raises your rate by 10 percent for three to five years after you have a claim, that could easily exceed the amount the insurer paid beyond the deductible," says Ross. Whatever deductible you choose, keep enough money in an emergency fund to self-insure up to the deductible -- or even a few hundred dollars more. The risk of self-insuring may not be as high as you think. The average person files a homeowners insurance claim only once every eight to 10 years, says Jeanne Salvatore of the Insurance Information Institute. You could take the money you save in premiums and add it to your emergency fund each year so that you're prepared when you do have a claim, recommends Ross. You could also use the extra money to boost your dwelling, property and liability coverage levels by tens of thousands of dollars.

When buying homeowners insurance, be sure that you're buying enough coverage to rebuild your home, if necessary. Don't look at market prices for homes, but rather at the for your home, which would include removing what's left of your home, buying new building materials, and labor. "Guaranteed replacement" policies should cover the whole cost, while "replacement cost" coverage often covers less than the full amount. Check your policy to see what kind you have, and be sure that your home's value isn't being understated.

Wednesday, June 10, 2015

3 Canceled Shows That Could Do Wonders for Netflix Stock

Other than the occasional short squeeze, nothing drives Netflix (NASDAQ: NFLX  ) stock so much as exclusive content. But don't take my word for it. Witness what happened after House of Cards and Hemlock Grove pushed viewing hours to new highs. (More than 4 billion, according to the latest data.)

Netflix stock has more than doubled year to date and is up nearly 250% since last summer.

NFLX Total Return Price Chart

NFLX Total Return Price data by YCharts.;

If original content is at least partially responsible for the rally, then the natural question for investors is: What's next? We know Jenji Kohan's Orange Is the New Black is on the way. Other in-development projects include a second season of House of Cards and Sense8 from the Wachowskis and J. Michael Straczynski of Babylon 5 fame.

And after that? Surely there are other small projects in the works, plus a rotating schedule of exclusive content that includes a big deal with Walt Disney (NYSE: DIS  ) for rebroadcasting of the highly successful Marvel films. (The Iron Man franchise alone already accounts for $2.4 billion in worldwide box office receipts.) 

But it'll take years to get all those movies. In the meantime, resuscitating popular but recently canceled television shows could become a catalyst for Netflix stock even as Amazon.com (NASDAQ: AMZN  ) sharpens its focus on five originals: two adult comedies (i.e., Alpha House and Betas) and three kids' shows (i.e., Annebots, Creative Galaxy, and Tumbleaf).

To be clear, I'm not talking about doubling down on Arrested Development. I'm talking about newer shows with a niche following, such as The Killing. Here are three canceled shows whose earlier seasons are already available on Netflix:

Warehouse 13 
Among all the things I saw at Denver Comic-Con earlier this month, nothing surprised or delighted me so much as getting to meet Eddie McClintock, who plays Agent Pete Lattimer in this soon-to-be defunct SyFy channel show about hunting down and "bagging and tagging" powerful artifacts for storage in a mysterious warehouse located in the South Dakota wilderness. (Netflix ratings: 886,436; IMDb stars: 7.3)

Terriers 
A seedy, funny, and surprising detective series starring Donal Logue as a recovering alcoholic P.I. operating without a license and whose partner and best friend is a former thief played by Michael Raymond-James. (Netflix ratings: 115,593; IMDb stars: 8.1)

Dollhouse 
Another Joss Whedon show canceled early -- (cough) Firefly (cough) -- that starred Eliza Dushku as one of a number of programmable "dolls" for hire through their employers, a network of corporate-controlled "dollhouses." (Netflix ratings: 863,535; IMDb stars: 7.3)

Skeptics will argue that Netflix would do better developing entirely new properties. Trouble is, promoting new shows isn't cheap. Netflix spent $129 million on marketing in the first quarter alone, about even with last year's Q1. A rush of newer originals could make it harder to keep a lid on costs.  

Cult hits such as Warehouse 13 don't need the same marketing support. Think about it: McClintock and co-stars Joanne Kelly, Saul Rubinek, and Allison Scagliotti have already won over the more than 800,000 who have rated the show on Netflix. That's a powerful tailwind, one that might prove better at boosting Netflix's bottom line than would investing in an untested idea. 

Now it's your turn to weigh in. Would you have Netflix bring back any of these shows? Leave a comment to let us know what you think, and whether you would buy, sell, or short Netflix stock at current prices.

Go ahead, touch that dial
The television landscape is changing quickly, with new entrants such as Netflix and Amazon.com disrupting traditional networks. The Motley Fool's new free report "Who Will Own the Future of Television?" details the risks and opportunities in TV. Click here to read the full report!

Tuesday, June 9, 2015

Has Broadridge Financial Solutions Made You Any Real Money?

Although business headlines still tout earnings numbers, many investors have moved past net earnings as a measure of a company's economic output. That's because earnings are very often less trustworthy than cash flow, since earnings are more open to manipulation based on dubious judgment calls.

Earnings' unreliability is one of the reasons Foolish investors often flip straight past the income statement to check the cash flow statement. In general, by taking a close look at the cash moving in and out of the business, you can better understand whether the last batch of earnings brought money into the company, or merely disguised a cash gusher with a pretty headline.

Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Broadridge Financial Solutions (NYSE: BR  ) , whose recent revenue and earnings are plotted below.

Source: S&P Capital IQ. Data is current as of last fully reported fiscal quarter. Dollar values in millions. FCF = free cash flow. FY = fiscal year. TTM = trailing 12 months.

Over the past 12 months, Broadridge Financial Solutions generated $213.2 million cash while it booked net income of $160.9 million. That means it turned 9.0% of its revenue into FCF. That sounds OK.

All cash is not equal
Unfortunately, the cash flow statement isn't immune from nonsense, either. That's why it pays to take a close look at the components of cash flow from operations, to make sure that the cash flows are of high quality. What does that mean? To me, it means they need to be real and replicable in the upcoming quarters, rather than being offset by continual cash outflows that don't appear on the income statement (such as major capital expenditures).

For instance, cash flow based on cash net income and adjustments for non-cash income-statement expenses (like depreciation) is generally favorable. An increase in cash flow based on stiffing your suppliers (by increasing accounts payable for the short term) or shortchanging Uncle Sam on taxes will come back to bite investors later. The same goes for decreasing accounts receivable; this is good to see, but it's ordinary in recessionary times, and you can only increase collections so much. Finally, adding stock-based compensation expense back to cash flows is questionable when a company hands out a lot of equity to employees and uses cash in later periods to buy back those shares.

So how does the cash flow at Broadridge Financial Solutions look? Take a peek at the chart below, which flags questionable cash flow sources with a red bar.

Source: S&P Capital IQ. Data is current as of last fully reported fiscal quarter. Dollar values in millions. TTM = trailing 12 months.

When I say "questionable cash flow sources," I mean items such as changes in taxes payable, tax benefits from stock options, and asset sales, among others. That's not to say that companies booking these as sources of cash flow are weak, or are engaging in any sort of wrongdoing, or that everything that comes up questionable in my graph is automatically bad news. But whenever a company is getting more than, say, 10% of its cash from operations from these dubious sources, investors ought to make sure to refer to the filings and dig in.

With 29.5% of operating cash flow coming from questionable sources, Broadridge Financial Solutions investors should take a closer look at the underlying numbers. Within the questionable cash flow figure plotted in the TTM period above, stock-based compensation and related tax benefits provided the biggest boost, at 9.3% of cash flow from operations. Overall, the biggest drag on FCF came from capital expenditures, which consumed 16.0% of cash from operations.

A Foolish final thought
Most investors don't keep tabs on their companies' cash flow. I think that's a mistake. If you take the time to read past the headlines and crack a filing now and then, you're in a much better position to spot potential trouble early. Better yet, you'll improve your odds of finding the underappreciated home-run stocks that provide the market's best returns.

Can your portfolio provide you with enough income to last through retirement? You'll need more than Broadridge Financial Solutions. Learn how to maximize your investment income and get "The 3 DOW Stocks Dividend Investors Need." Click here for instant access to this free report.

We can help you keep tabs on your companies with My Watchlist, our free, personalized stock tracking service.

Add Broadridge Financial Solutions to My Watchlist.

Monday, June 8, 2015

What Does Wall Street See for Shanda Games's Q1?

Shanda Games (Nasdaq: GAME  ) is expected to report Q1 earnings on May 23. Here's what Wall Street wants to see:

The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Shanda Games's revenues will contract -21.7% and EPS will shrink -27.3%.

The average estimate for revenue is $172.8 million. On the bottom line, the average EPS estimate is $0.16.

Revenue details
Last quarter, Shanda Games reported revenue of $172.1 million. GAAP reported sales were 19% lower than the prior-year quarter's $215.1 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Last quarter, non-GAAP EPS came in at $0.15. GAAP EPS of $0.12 for Q4 were 29% lower than the prior-year quarter's $0.17 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Recent performance
For the preceding quarter, gross margin was 65.4%, 390 basis points better than the prior-year quarter. Operating margin was 29.8%, 210 basis points worse than the prior-year quarter. Net margin was 19.8%, 260 basis points worse than the prior-year quarter.

Looking ahead

The full year's average estimate for revenue is $743.0 million. The average EPS estimate is $0.69.

Investor sentiment
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 300 members out of 311 rating the stock outperform, and 11 members rating it underperform. Among 38 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 31 give Shanda Games a green thumbs-up, and seven give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Shanda Games is outperform, with an average price target of $4.38.

Software and computerized services are being consumed in radically different ways, on new and increasingly mobile devices. Many old leaders will be left behind. Whether or not Shanda Games makes the coming cut, you should check out the company that Motley Fool analysts expect to lead the pack in "The Next Trillion-dollar Revolution." Click here for instant access to this free report.

Add Shanda Games to My Watchlist.

Thursday, June 4, 2015

Can AMD Finally Find Its Own Way?

On Thursday, Advanced Micro Devices (NYSE: AMD  ) will release its latest quarterly results. The key to making smart investment decisions on stocks reporting earnings is to anticipate how they'll do before they announce results, leaving you fully prepared to respond quickly to whatever inevitable surprises arise.

AMD has struggled throughout its existence, laboring in the shadow of Intel (NASDAQ: INTC  ) during the heyday of the PC and more recently falling behind many other rivals in the mobile revolution. Can the company finally get its strategy right, or is it doomed to failure in both market niches? Let's take an early look at what's been happening with AMD over the past quarter and what we're likely to see in its quarterly report.

Stats on AMD

Analyst EPS Estimate

($0.17)

Year-Ago EPS

$0.12

Revenue Estimate

$1.05 billion

Change From Year-Ago Revenue

(34%)

Earnings Beats in Past 4 Quarters

2

Source: Yahoo! Finance.

Will AMD get the chip off its shoulder this quarter?
Analysts haven't had much hope for AMD's earnings in recent months, having widened their loss estimates for the just-finished quarter by $0.01 per share. Their call for full-year 2013 has gotten worse still, with a $0.04 per share increase in expected losses. The stock has reflected similarly pessimism, dropping 9% since early January.

AMD has a long history of struggling behind Intel's dominance in the PC market. Yet even with its also-ran status in PCs, AMD remains sensitive to the conditions of the overall industry, as the stock fell alongside Intel after last week's report of plunging PC sales.

In order to survive, AMD appears to be trying its hand at certain niche markets. Last month, AMD invested in Aviary, a privately held company that makes photo-editing software. If the move gets AMD better exposure in high-potential areas like high-level digital photography and professional graphic design, then it could give it a competitive advantage over Intel and other rivals.

Yet it's unclear that the niches that AMD is targeting are big enough to keep the company moving forward. For instance, reports that Microsoft (NASDAQ: MSFT  ) will include AMD chips in its coming new upgrade to its Xbox gaming console were enough to send AMD stock soaring. Yet even with Microsoft's past success in the gaming space, it's far from clear whether a refreshed Xbox will have the same success in light of increased online gaming. Moreover, even success for Microsoft might not give AMD's revenue enough of a boost to make a lasting difference.

In AMD's quarterly report, watch for more substantial initiatives to try to penetrate the mobile market or other high-potential specialty areas. Without something to distinguish AMD from its competitors, it's hard to see the stock moving higher in the near future.

AMD knows all too well that when it comes to dominating markets, it doesn't get much better than Intel's position in the PC microprocessor arena. However, that market is maturing, and Intel finds itself in a precarious situation longer term if it doesn't find new avenues for growth. In this premium research report on Intel, our analyst runs through all of the key topics investors should understand about the chip giant. Click here now to learn more.

Click here to add AMD to My Watchlist, which can find all of our Foolish analysis on it and all your other stocks.

Wednesday, June 3, 2015

How 'Chained CPI' Will Hit Your Pocketbook

President ObamaGetty Images President Obama's new budget proposal includes changing a couple of key inflation calculations to something called a "chained CPI." The shift is getting a lot of attention right now because of the expected effect it will have on individuals. There are two key places where a chained CPI -- short for consumer price index -- will have a direct impact on your pocketbook: income taxes and Social Security benefits. All else being equal, over time, your income taxes will be higher and your Social Security benefits will be lower than they are under current inflation calculations. The key difference between the chained CPI and the traditional consumer price index is how the index measures consumer behavior. The chained CPI assumes that as prices rise on one product, some portion of consumers will be willing to substitute less expensive alternatives for what they used to buy. That changes the product weightings used in the inflation calculation. By incorporating information from those new product weightings, the chained CPI typically produces a lower inflation level. Here's how it works. The Impact on Income Taxes If you pay income taxes, your tax bracket is determined by the amount of taxable income you make. The cutoffs for each bracket generally rise over time with inflation. The two charts below show the IRS "Schedule X" brackets for single taxpayers; the first is for 2012, and the second is what's currently expected for 2013: IRS ChartChart for 2012 from the U.S. Internal Revenue Service Chart for 2013 from the US Internal Revenue ServiceChart for 2013 from the U.S. Internal Revenue Service While the 39.6 percent tax rate is new for 2013, note that the other brackets have higher cutoffs for 2013 than they did for 2012. That's thanks to the inflation adjustment made to the tax brackets. If the law is changed so that the chained CPI is used, the tops of those brackets are expected to rise more slowly, exposing more of your income to higher tax rates than under current law. The Effect on Social Security Benefits Similarly, Social Security benefits are increased based on the inflation rate. By tying the payment increases to the chained CPI -- an inflation rate that grows more slowly than the current measure -- those benefit payments will grow less quickly as well. As a result, over time your Social Security checks will be smaller than they would have been under the old inflation calculation. The annual changes aren't too extreme -- they're estimated to be somewhere in the vicinity of 0.1 percent to 0.3 percent per year, depending on what the future brings. But over time, it adds up to real money for those who pay income taxes or receive Social Security checks, with official estimates in the neighborhood of $340 billion in higher taxes and lower costs over the next 10 years. Is It Better? Is It Fair? To some extent, the chained CPI is more effective at measuring the behavior changes that we all make whenever possible to save some cash. For example, if you've switched to generic medications whenever they're available, you're doing exactly what the chained CPI expects you to do. Likewise, if you started carpooling or taking the bus in response to higher gas prices, you're changing your behavior based on higher prices, just like the chained CPI projects. On the flip side, of course, not all costs are easily switchable, especially for the seniors who rely on Social Security. For instance, health care costs have been rising faster than the overall inflation rate for decades, and older folks generally have higher health care costs than younger ones do. As a result, the change to a chained CPI will very likely make the gap between income growth and health care spending growth even more painful for seniors on Social Security. The Big Picture Still, if slowing the rate of benefit increases puts off the day of reckoning for when the Social Security Trust Fund runs out of cash and slashes benefits by around 25 percent, it may be worth it. That date is currently estimated to be a mere 20 years away -- well within the expected life span of most current workers and even some early retirees. To make it worse, if the CBO's recent release on Social Security is any indication, the next Social Security Trustees' Report may even pull that date even closer. Given a choice between a slower rate of growth or a hard slash of 25 percent at some point in the not-too-distant future, neither option seems ideal. But still, a slower rate of growth is a lot less painful than waking up one day to find your sole source of income has shrunk by a quarter of its former value.

Your age when you collect Social Security has a big impact on the amount of money you ultimately get from the program. The key age to know is your full retirement age. For people born between 1943 and 1954, full retirement age is 66. It gradually climbs toward 67 if your birthday falls between 1955 and 1959. For those born in 1960 or later, full retirement age is 67. You can collect Social Security as soon as you turn 62, but taking benefits before full retirement age results in a permanent reduction of as much as 25% of your benefit.

Monday, June 1, 2015

Benzinga Weekly Preview: U.S. Data In Focus

Related STZ Big Lots Maintains Sheen, Hits 52-Week High - Analyst Blog AB InBev Hits 52-Week High as World Cup Frenzy Rises - Analyst Blog Bulls Charge the Street as Traders Cheer FOMC Minutes (Fox Business) Related UNF Company news for April 03, 2014 - Corporate Summary #PreMarket Primer: Thursday, April 3: ECB Outcome Awaited

With Independence Day shutting US markets down for a long weekend, next week will be a slow week for earnings reports. However, an influx of economic data will more than make up for it and give investors plenty to consider. US data is expected to show that the nation’s recovery is back on track with both jobs data and PMI data forecast to impress. Fed Chair Janet Yellen is set to speak at the International Monetary Fund on Wednesday, a talk that will be closely watched as investors look for clues about the bank’s policy tightening timeline.

Key Earnings Reports

Next week, investors will be waiting for several key earnings reports including Paychex (NASDAQ: PAYX), Constellation Brands (NYSE: STZ) and Unifirst (NYSE: UNF)

Paychex Inc

Paychex is expected to report fourth quarter EPS of $0.40 on revenue of $617.35 million, compared to last year’s EPS of $0.38 on revenue of $585.30 million.

On March 28, Merrill Lynch maintained Paychex at a Neutral rating with a $47.00 price objective, noting that competition among payroll providers was high and may have an impact on the company’s growth.

“PAYX continues to face increased competition from SaaS-based payroll providers & Intuit, among others. Management noted that both its SurePayroll (SaaS offering) and full-service offerings with added online features are growing well. We expect Paychex will compete effectively but have concerns that growth in SaaS-based payroll offerings may limit pricing power for the full-service offering over time. Paychex should benefit from an improving cyclical market and greater reliance on payroll data due to healthcare reform. However, questions remain around the competitive environment. Valuation incorporates much of the improving cycle, with PAYX trading at 22x CY15E EPS, in line with its 22x 10 year median forward P/E. We maintain our $47 price objective, based on 24.5x CY15E EPS of $1.92.”

A day earlier, on March 27, Credit Suisse had a similar opinion on Paychex with a Neutral rating and a $41.00 price target. The analysts at Credit Suisse said the company’s shares are already fully valued and that there was little upside to be seen in the near future.

“Despite investments in the business via M&A, JVs, and revamping its omnichannel user experience, PAYX's profitability continues to increase. While operating margin (ex-float) guidance suggests a sequential and y-o-y contraction we view this as conservative given the ~130 bps of expansion through the first nine months. PAYX currently trades at ~24x our CY14 EPS, a considerable premium to the peer group average of 17x). With PAYX's relatively anemic growth prospects (high-single-digit EPS growth) we do not see any significant upside to the current share price.”

On June 27, Morgan Stanley maintained Paychex at an Underweight rating, noting that competition could stifle the company’s growth.

“Although PAYX has a strong recurring revenue business model, its exposure to the smaller businesses creates potential for pricing pressure and share loss to cheaper SaaS-based solutions. High total yield but increasing payout ratio indicates slowdown in growth. Growth opportunities in HR exist but we believe these are reflected in the multiple after recent runup in share price.”

S&P Capital IQ maintained Paychex at a Strong Sell rating with a $35.00 target price on June 21, saying that the stock is notably overvalued.

“We downgraded our opinion on the shares to Strong Sell from Hold in March 2014, based largely on valuation. We see lacking top-line growth, largely reflecting a tepid expansion of the U.S. economy and persistently low interest rates. While we have noted improving domestic employment data, we believe it is more than adequately reflected in the stock price. We see the stock as notably overvalued, notwithstanding a healthy balance sheet and considerable dividend.”

Constellation Brands

Constellation Brands is expected to report EPS of $0.92, compared to last year’s EPS of $0.38.

On June 23, Merrill Lynch maintained Constellation Brands at a Buy rating with a $95.00 price objective. The firm said it expects to see strong EPS growth over the next three years.

“We look for mgmt. to provide an update to the current state of the business. Key areas of focus will be 1) Progress on Crown integration and brewery expansion plans 2) Comments on US beer industry pricing, 3) Updated commentary on wine/spirits trends in the US market. Our $95 PO is based on 21.8x CY15 EPS of $4.37. This is a 15-20% premium to its  international brewer peers, which is in our view is warranted by the higher than average EPS growth (led by imported beer) we expect over the next three years.  Our trade checks and recent competitor comments and results indicate that US  beverage alcohol market is healthy into the upcoming summer season and that STZ trends in beer and wine have broadly held. Our PO reflects this dynamic as well as the potential for STZ to grow faster than its food/beverage peers in CY14.”

On June 21, S&P Capital IQ maintained Constellation Brands at a Strong Buy rating with a $98.00 price target. The analysts at S&P cited the company’s 2012 agreement with Anheuser-Busch as reason for their optimism.

“We view the shares as very attractive, trading at a discount to peers. In June 2012, STZ signed an agreement with Anheuser-Busch InBev SA/ NV (A-B InBev) to buy the remaining 50% interest in Crown Imports LLC that it does not already own for $1.85 billion. To address antitrust concerns from the Department of Justice (DOJ), A-B InBev agreed to sell STZ the rights in perpetuity to Grupo Modelo brands distributed by Crown in the U.S. and a state-of-the-art Mexican brewery for an additional cost of $2.9 billion. The acquisition closed in June 2013.”

Unifirst Corporation

Unifirst is expected to report third quarter EPS of $1.42 on revenue of $349.24 million, compared to last year’s EPS of $1.43 on revenue of $355.76 million.

S&P Capital IQ maintained UniFirst at a sell rating with a $96.00 price target on June 21. The analysts at S&P said they expect to see the company’s growth start to fizzle out this year.

“We see a wide range of customizable product and service offerings and high levels of customer service as underlying strengths in UNF's business. However, after benefiting over the last few years from large account sales, significant growth in its flame resistant garment business that was driven by oil and natural gas exploration, and higher pricing and merchandise recovery charges, we expect the company's top-line and earnings growth to moderate in FY 14. Our outlook is also tempered by continuing high unemployment levels in the U.S. and Canada, as UNF's Core Laundry segment revenue is largely driven by the number of employees at its customers.”

Economic Releases

After US data disappointed this week, a spate of new releases from America will be highly anticipated next week. The unemployment rate is expected to have remained constant at 6.3 percent while US employers likely added nearly 200,000 workers in June. PMI reports are forecast to show expansion in both the services and manufacturing sectors within the US as well.

Also on the radar will be the European Central Bank’s policy meeting, which is set for Thursday. The bank isn’t expected to make any moves as they eased considerably at June’s meeting, but the press conference following the meeting will likely shed some light on the bank’s expectations for the bloc’s economy now that the new easing package is falling into place.

Daily Schedule:

Monday

Earnings Releases Expected:  No notable releases expected Economic Releases Expected: Chinese manufacturing PMI, Japanese Tankan survey, US pending home sales, German retail sales and Japanese housing starts

Tuesday

Earnings Expected: A. Schulman (NASDAQ: SHLM), Acuity Brands (NYSE: AYI), Franklin Covey (NYSE: FC) and Paychex (NASDAQ: PAYX) Economic Releases Expected: US ISM manufacturing PMI, US redbook, British manufacturing PMI, German unemployment rate, French manufacturing PMI, Italian manufacturing PMI, Spanish manufacturing PMI and Reserve Bank of Australia interest rate decision

Wednesday

Earnings Expected: Constellation Brands (NYSE: STZ), Synnex (NYSE: SNX) and Unifirst (NYSE: UNF). Economic Releases Expected:  Chinese services PMI, US oil inventory data, eurozone PPI and British construction PMI

Thursday

Earnings Expected From: Markets Close At 1pm ET Economic Releases Expected:  US ISM non-manufacturing PMI, US unemployment rate, US trade balance, European Central Bank interest rate decision, Eurozone retail sales, British services PMI, French services PMI, German services PMI, Spanish services PMI and eurozone services PMI.

Friday

U.S. Markets Closed For July 4 Holiday

Posted-In: European Central Bank Federal ReserveAnalyst Color Earnings News Eurozone Previews Forex Global Economics Federal Reserve Pre-Market Outlook Markets Trading Ideas Best of Benzinga

© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  Most Popular Regarding Afrezza, FDA Statement: Rackspace Down 7% On Rumor It Can't Find Buyer Apple TV Vs. Android TV Vs. Fire TV Vs. PlayStation TV UPDATE: Credit Suisse Reiterates On Schlumberger Limited Following Impressive Analyst Meeting Pfizer, Bristol-Myers Squibb Announce Positive Opinion For Treatments #PreMarket Primer: Friday, June 27: U.S. Data Fuels Fed Rate Hike Debate Related Articles (AYI + FC) Benzinga Weekly Preview: U.S. Data In Focus Top 4 Mid-Cap Stocks In The Diversified Electronics Industry With The Highest EPS Around the Web, We're Loving...